Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours Β· Estimated delivery Sep 20 - Sep 25
The approval was based on the TAZPOWER clinical trial (NCT03098797), which demonstrated improved knee extensor muscle strength during open-label treatment over 168 weeks
Not a sales pitch
The majority of patients in the second study experienced treatment-related adverse events, likely due to the nature of drug delivery (ie, intravenous infusion)
Lot Traceability and Public COA Library Vial-printed lot numbers route back to one consolidated documentation file: HPLC traces for all three peptides, the multi-target mass spectrum, the ICP copper reading, and the endotoxin result
US$ 22.34
US$ 27.36
US$ 25.00
US$ 24.41
US$ 23.65
